Role of vaccination in patients with human monkeypox virus and its cardiovascular manifestations

Ann Med Surg (Lond). 2024 Jan 4;86(3):1506-1516. doi: 10.1097/MS9.0000000000001674. eCollection 2024 Mar.ABSTRACTHuman monkeypox, caused by the monkeypox virus (MPXV), is an emerging infectious disease with the potential for human-to-human transmission and diverse clinical presentations. While generally considered milder than smallpox, it can lead to severe cardiovascular complications. The virus primarily spreads through contact with infected animals or through human-to-human transmission. Cardiovascular involvement in human monkeypox is rare but has been associated with myocarditis, pericarditis, arrhythmias, and even fulminant myocardial infarction. Vaccination plays a crucial role in preventing and controlling monkeypox, but the eradication of smallpox has left global populations vulnerable. This review explores the cardiovascular manifestations of human monkeypox, the role of vaccination in disease prevention, and the importance of continued research and development of effective vaccines to protect against this emerging infectious threat. The global impact of monkeypox outbreaks, particularly on vulnerable populations, further highlights the importance of understanding and addressing this disease.PMID:38463133 | PMC:PMC10923390 | DOI:10.1097/MS9.0000000000001674
Source: Annals of Medicine - Category: Internal Medicine Authors: Source Type: research